Debiopharm Diagnostics Leads Investment Round in GenePOC With Emerillon Capital
Lausanne, Switzerland (ots/PRNewswire) - GenePOC is a Canadian company which has developed a rapid, innovative, low cost MDx platform for the detection of infectious diseases Debiopharm Diagnostics [https://www.debiopharm.com/about-us/debiopharm-diagnostics-s-a.html ], part of Debiopharm Group [https://www.debiopharm.com/about-us/debiopharm-group.html ](TM), is proud ...